LOPID CAP 300MG DIN 00599026
Health Canada record
| Active ingredient(s) | GEMFIBROZIL 300 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AB04 GEMFIBROZIL |
| Original market date | 31-Dec-1984 |
| Current status date | 18-Jul-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GEMFIBROZIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02142074 | TEVA-GEMFIBROZIL | TEVA CANADA LIMITED | Tablet | GEMFIBROZIL 600 MG | Marketed |
| 01979582 | APO-GEMFIBROZIL | APOTEX INC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 01979574 | APO-GEMFIBROZIL CAP 300MG USP | APOTEX INC | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02230580 | DOM-GEMFIBROZIL | DOMINION PHARMACAL | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02241608 | DOM-GEMFIBROZIL | DOMINION PHARMACAL | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 00851922 | GEMFIBROZIL CAP 300MG | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 00851930 | GEMFIBROZIL TAB 600MG | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02136031 | GEMFIBROZIL-300 - CAP | PRO DOC LIMITEE | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02136058 | GEMFIBROZIL-600 - TAB 600MG | PRO DOC LIMITEE | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 00659606 | LOPID 600MG | PFIZER CANADA ULC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02185407 | MYLAN-GEMFIBROZIL | MYLAN PHARMACEUTICALS ULC | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02230476 | MYLAN-GEMFIBROZIL | MYLAN PHARMACEUTICALS ULC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02058456 | NU-GEMFIBROZIL CAP 300MG | NU-PHARM INC | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02058464 | NU-GEMFIBROZIL TAB 600MG | NU-PHARM INC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02229604 | PENTA-GEMFIBROZIL | PENTAPHARM LTD. | Tablet | GEMFIBROZIL 600 MG | Cancelled (Unreturned Annual) |
| 02254859 | PHL-GEMFIBROZIL | PHARMEL INC | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02254867 | PHL-GEMFIBROZIL | PHARMEL INC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02230183 | PMS-GEMFIBROZIL | PHARMASCIENCE INC | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02239951 | PMS-GEMFIBROZIL | PHARMASCIENCE INC | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02242126 | RIVA-GEMFIBROZIL | LABORATOIRE RIVA INC. | Tablet | GEMFIBROZIL 600 MG | Cancelled Post Market |
| 02242390 | SCHEINPHARM GEMFIBROZIL | SCHEIN PHARMACEUTICAL CANADA INC. | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
| 02241704 | TEVA-GEMFIBROZIL | TEVA CANADA LIMITED | Capsule | GEMFIBROZIL 300 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 2299 | 2001-01-17 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for GEMFIBROZIL
4 valid EDQM Certificates of Suitability from 4 holders. 8 active FDA Drug Master Files.
Request a quote for LOPID CAP 300MG